Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified […]
As researchers learn more about COVID-19, it has become increasingly clear that certain groups, including those who have diabetes or obesity, are at higher risk of […]